| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| Hearing loss risk indicators [Identifier] | NLM | Disease characterization |
Including Alzheimer's Disease (AD)/AD-Related Dementias (ADRD) diagnosis and multiple chronic conditions (MCCs) |
NIH CDEs |
|
| # | Datatype |
|---|---|
|
|
Value List |
| # | Permissible value | Value meaning name | Value meaning code | Value meaning definition | Code system name |
|---|---|---|---|---|---|
|
|
Assisted ventilation | Assisted ventilation | LA12671-6 | Description: Mechanical ventilation or respirator | LOINC |
|
|
Caregiver concern about hearing | Caregiver concern about hearing | LA12667-4 | Description: Caregiver concern regarding hearing, speech, language, or developmental delay | LOINC |
|
|
Chemotherapy | Chemotherapy | LA6172-6 | N/A | LOINC |
|
|
Craniofacial anomalies | Craniofacial anomalies | LA12675-7 | Description: Craniofacial anomalies, including those that involve the pinna, ear canal, ear tags, ear pits, and temporal bone anomalies. | LOINC |
|
|
ECMO | ECMO | LA12670-8 | Description: Extracorporeal Membrane Oxygenation | LOINC |
|
|
Exchange transfusion for Hyperbilirubinemia | Exchange transfusion for Hyperbilirubinemia | LA12673-2 | Description: hyperbilirubinemia bad enough to require exchange transfusion | LOINC |
|
|
Family Hx of hearing loss | Family Hx of hearing loss | LA12668-2 | Description: Family history of permanent hearing loss occurring during childhood | LOINC |
|
|
Head trauma | Head trauma | LA12679-9 | Description: Head trauma, especially basal skull/temporal bone fracture that requires hospitalization. | LOINC |
|
|
ICU stay > 5 days | ICU stay > 5 days | LA12669-0 | Description: Neonatal intensive care stay of more than 5 days (or any of the following regardless of length of stay) | LOINC |
|
|
In utero infection(s) | In utero infection(s) | LA12674-0 | Description: In utero infections, such as CMV, herpes, rubella, syphilis, and toxoplasmosis. | LOINC |
|
|
Neurodegenerative disorders | Neurodegenerative disorders | LA12677-3 | Description: Neurodegenerative disorders, such as Hunter syndrome, or sensory motor neuropathies, such as Friedreich ataxia and Charcot-Marie-Tooth syndrome. | LOINC |
|
|
None | None | LA137-2 | N/A | LOINC |
|
|
Ototoxic medication use | Ototoxic medication use | LA12672-4 | Description: exposure to ototoxic medications such aminoglycosides ( gentimycin/ tobramycin) or loop diuretics (furosemide/Lasix) | LOINC |
|
|
Physical findings of syndromes that include hearing loss | Physical findings of syndromes that include hearing loss | LA12681-5 | Description: Physical findings, such as white forelock, that are associated with a syndrome known to include a sensorineural or permanent conductive hearing loss. | LOINC |
|
|
Postnatal infections | Postnatal infections | LA12678-1 | Description: Culture-positive postnatal infections associated with sensorineural hearing loss, including confirmed bacterial and viral (especially herpes viruses and varicella) meningitis. | LOINC |
|
|
Syndromes associated with hearing loss | Syndromes associated with hearing loss | LA12676-5 | Description: Syndromes associated with hearing loss or progressive or late-onset hearing loss, such as neurofibromatosis, osteopetrosis, and Usher syndrome; other frequently identified syndromes include Waardenburg, Alport, Pendred, and Jervell and Lange-Nielson. | LOINC |
| # | Name | Origin | Origin | Concept type |
|---|---|---|---|---|
|
|
Hearing loss risk indicators | LOINC - Part - Component | LP98852-4 | object |
|
|
Prid [Presence or Identity] | LOINC - Part - Property | LP6850-4 | property |
|
|
Patient | LOINC - Part - Super System | LP6985-8 | property |
|
|
Pt [Point in time (spot)] | LOINC - Part - Time | LP6960-1 | property |
|
|
Nom | LOINC - Part - Scale | LP7750-5 | property |
|
|
P' | LOINC - Part - Fragments for synonyms | LP75922-2 | property |
| # | Definition | Tags |
|---|---|---|
|
|
This question should be answered as part of the order and/or result of new born screen for hearing loss. It is intended to capture the risk factors identified by the Joint committee on Infant Hearing (JCIH) in appendix 2 of their recommendations (Pediatrics 2007;120;898-921). The user should always provide an answer (none if no risk factors exist) and otherwise pick as many answers as apply. The observations must be included IF the hearing screening result is delivered as part of this report. | TERM DEFINITION/DESCRIPTION(S) |
| # | Designation | Tags |
|---|---|---|
|
|
Hearing loss risk indicators [Identifier] | Long Common Name Question Text |
|
|
Hearing loss risk indicators | Shortname |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
58232-0 | LOINC | 2.56 |
|
|
7yTMaJxU37z | NLM CDEs | 12-02-2025-download |